mRNA |
KU 0060648 |
CTRPv2 |
pan-cancer |
AAC |
0.0023 |
0.9 |
mRNA |
ibrutinib |
CTRPv2 |
pan-cancer |
AAC |
0.0027 |
0.9 |
mRNA |
AGK-2 |
CTRPv2 |
pan-cancer |
AAC |
0.0022 |
1 |
mRNA |
doxorubicin:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.0019 |
1 |
mRNA |
decitabine:carboplatin (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.0016 |
1 |
mRNA |
sirolimus:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.0017 |
1 |
mRNA |
WZ4002 |
CTRPv2 |
pan-cancer |
AAC |
0.0022 |
1 |
mRNA |
ifosfamide |
CTRPv2 |
pan-cancer |
AAC |
-0.0026 |
1 |
mRNA |
BRD-K20514654 |
CTRPv2 |
pan-cancer |
AAC |
-0.0025 |
1 |
mRNA |
GSK-1904529A |
GDSC1000 |
pan-cancer |
AAC |
0.0017 |
1 |